Your session is about to expire
← Back to Search
Behavioural Intervention
MPACT Intervention for Patients (MPACT Trial)
N/A
Waitlist Available
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Staff providing methadone treatment services at the enrolled opioid treatment programs
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
Summary
The trial of Methadone Patient Access to Collaborative Treatment (MPACT) will establish the impact of the intervention on patient outcomes of methadone treatment retention and in treatment overdose. It will also establish the impact of patient and staff trauma symptoms and clinic practice change on MPACT intervention implementation.
Eligible Conditions
- Staph Infection
- Patients
- Opioid Use Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Days in Treatment to treatment interruption
In Treatment- Point in time
Number of patients reporting opioid overdoses while in methadone treatment
+1 moreSecondary outcome measures
Number of patients and staff experiencing post traumatic stress symptoms
Number of staff experiencing vicarious (work related) stress
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: MPACT InterventionExperimental Treatment1 Intervention
Enrolled clinic staff will be exposed to the MPACT intervention components over the trial period. This includes accredited training, clinic self assessment, reflective supervision for counseling/peer/case management staff, and wellness education with navigation to trauma symptoms assessment and resources including trauma treatment. Periodic surveys of staff and patients will be conducted to assess outcome measures (primary and secondary) and patient chart reviews will verify patient outcomes.
Group II: Control for MPACTActive Control1 Intervention
Enrolled clinic staff will not receive any portion of the intervention. Periodic surveys of staff and patients will be conducted to assess outcome measures (primary and secondary) and patient chart reviews will verify patient outcomes.
Find a Location
Who is running the clinical trial?
University of ArizonaLead Sponsor
523 Previous Clinical Trials
155,253 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger